Catalog |
name |
Description |
price |
R-C-2166 |
Upadacitinib (ABT-494) CAS:1310726-60-3 |
Upadacitinib(ABT-494)is a potent and selective JAK inhibitors in development for rheumatoid arthritis.ABT-494 is approximately 74 fold selective for Jak1 over Jak2 in cellular assays dependent on specific,relevant cytokines.ABT-494 demonstrates efficacy in rat arthritis models. |
price> |
R-C-2167 |
Abrocitinib (PF-04965842) CAS:1622902-68-4 |
Abrocitinib(PF-04965842)is a potent,orally active and selective JAK1 inhibitor, with IC50s of 29 and 803nM for JAK1 and JAK2,respectively.Abrocitinib(PF-04965842)exhibits less active effect on TYK2(IC50,1.253μM),and inhibits phosphorylation of STAT1,STAT3 and STAT5 after stimulation.Effective in autoimmune disease. |
price> |
R-C-2168 |
Itacitinib (INCB39110) CAS:1334298-90-6 |
INCB39110 is a potent JAK1 tyrosine kinase inhibitor,which is currently in Phase II trials for the treatment of rheumatoid arthritis,myelofibrosis,rheumatoid arthritis and plaque psoriasis. |
price> |
R-C-2230 |
Hispidulin CAS:1447-88-7 |
Hispidulin(Dinatin),an active natrual ingredient in a number of traditional Chinese medicinal herbs,exhibits inhibitory activity against the oncogenic protein kinase Pim-1 with IC50 of 2.71μM.Hispidulin induces apoptosis through mitochondrial dysfunction and inhibition of P13k/Akt signalling pathway in HepG2 cancer cells.Hispidulin exerts anti-osteoporotic and bone resorption attenuating effects via activating the AMPK signaling pathway. |
price> |
R-C-2247 |
Scutellarin CAS: 27740-01-8 |
Scutellarin(Breviscapine,Breviscapin,Scutellarein-7-glucuronide),the major active principal flavonoids extracted from the Chinese herbal medicines Scutellaria baicalensis and Erigeron breviscapus(Vant.)Hand-Mazz,has many pharmacological effects,such as antioxidant,antitumor,antiviral,and antiinflammatory activities.Scutellarin can down-regulates the STAT3/Girdin/Akt signaling in HCC cells,and inhibits RANKL-mediated MAPK and NF-κB signaling pathway in osteoclasts. |
price> |
R-C-2385 |
Ruxolitinib (INCB018424) CAS:941678-49-5 |
Ruxolitinib(INCB018424)is the first potent,selective,JAK1/2 inhibitor to enter the clinic with IC50 of 3.3nM/2.8nM in cell-free assays,>130-fold selectivity for JAK1/2 versus JAK3.Ruxolitinib kills tumor cells through toxic mitophagy. Ruxolitinib induces autophagy and enhances apoptosis. |
price> |
R-C-2386 |
Cucurbitacin I CAS:2222-07-3 |
Cucurbitacin-I(Elatericin B,JSI 124,NSC 521777),a natural cell-permeable triterpenoid isolated from Cucurbitaceae,is a novel selective inhibitor of JAK2/STAT3. |
price> |
R-C-2562 |
HO-3867 CAS:1172133-28-6 |
HO-3867 is a selective and potent STAT3 inhibitor.HO-3867 selectively inhibited STAT3 phosphorylation,transcription,and DNA binding without affecting the expression of other active STATs.HO-3867 exhibited minimal toxicity toward noncancerous cells and tissues but induced apoptosis in ovarian cancer cells. |
price> |
R-C-2563 |
STATTIC CAS:19983-44-9 |
Stattic is a potent STAT3 inhibitor and inhibits STAT3 phosphorylation(at Y705 and S727).Stattic inhibits the binding of a high affinity phosphopeptide for the SH2 domain of STAT3.Stattic ameliorates the renal dysfunction in Alport syndrome (AS)mice. |
price> |
R-C-2692 |
NVP-BSK805 CAS:1092499-93-8 |
NVP-BSK805 is a JAK2 inhibor,which displays more than 20-fold selectivity towards JAK2 in vitro,as well as excellent selectivity in broader kinase profiling.In vivo,NVP-BSK805 exhibited good oral bioavailability and a long half-life. |
price> |